Nurture the needs of women at risk for prenatal complications

Healthcare researchers say it’s critical to get more women, Black and Latino participants in clinical trials. It can be done, but researchers and institutions must make the effort.

Improving patient monitoring through care-at-home services could help reduce maternal mortality, they say.

Opill will be available in stores and online in the first quarter of 2024.

If approved, nirsevimab would be the first immunization specifically to protect infants through their first RSV season. The Prescription Drug User Fee Act date is in the third quarter of 2023.

If approved, Perrigo’s Opill could be the first-ever nonprescription birth control pill.

Eylea now also treats retinopathy of prematurity, a leading cause of childhood blindness worldwide.